Possible immune adverse events as predictors of durable response to BRAF inhibitors in patients with BRAF V600–mutant metastatic melanoma

Autor: Ben-Betzalel, Guy, Baruch, Erez N., Boursi, Ben, Steinberg-Silman, Yael, Asher, Nethanel, Shapira-Frommer, Ronnie, Schachter, Jacob, Markel, Gal
Zdroj: In European Journal of Cancer September 2018 101:229-235
Databáze: ScienceDirect